These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 36402940)
1. Economic Burden of Comorbidities in Patients with Psoriasis in the USA. Wu JJ; Suryavanshi M; Davidson D; Patel V; Jain A; Seigel L Dermatol Ther (Heidelb); 2023 Jan; 13(1):207-219. PubMed ID: 36402940 [TBL] [Abstract][Full Text] [Related]
2. Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis. Feldman SR; Zhao Y; Shi L; Tran MH J Manag Care Spec Pharm; 2015 Oct; 21(10):874-88. PubMed ID: 26402388 [TBL] [Abstract][Full Text] [Related]
3. Clinical Burden of Concomitant Joint Disease in Psoriasis: A US-Linked Claims and Electronic Health Records Database Analysis. Skornicki M; Prince P; Suruki R; Lee E; Louder A Adv Ther; 2021 May; 38(5):2458-2471. PubMed ID: 33818686 [TBL] [Abstract][Full Text] [Related]
4. Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database. Feldman SR; Tian H; Gilloteau I; Mollon P; Shu M BMC Health Serv Res; 2017 May; 17(1):337. PubMed ID: 28482887 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis. Cai Q; Teeple A; Wu B; Muser E J Med Econ; 2019 Dec; 22(12):1290-1297. PubMed ID: 31262226 [No Abstract] [Full Text] [Related]
6. Burden of Herpes Zoster Among Patients with Psoriasis in the United States. Singer D; Thompson-Leduc P; Ma S; Gupta D; Cheng WY; Sendhil SR; Sundar M; Hagopian E; Stempniewicz N; Duh MS; Poston S Dermatol Ther (Heidelb); 2023 Nov; 13(11):2649-2668. PubMed ID: 37740149 [TBL] [Abstract][Full Text] [Related]
7. Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis. Feldman SR; Zhao Y; Shi L; Tran MH; Lu J Arthritis Care Res (Hoboken); 2015 May; 67(5):708-17. PubMed ID: 25303478 [TBL] [Abstract][Full Text] [Related]
8. Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States. Hanna ML; Singer D; Valdecantos WC Curr Med Res Opin; 2021 May; 37(5):735-742. PubMed ID: 33622113 [TBL] [Abstract][Full Text] [Related]
9. Real-World Claims Analyses of Comorbidity Burden, Treatment Pattern, Healthcare Resource Utilization, and Costs in Pediatric Psoriasis. Edson-Heredia E; Anderson S; Guo J; Zhu B; Malatestinic WN; Wine-Lee L; Swanson E Adv Ther; 2021 Jul; 38(7):3948-3961. PubMed ID: 34091866 [TBL] [Abstract][Full Text] [Related]
10. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease. King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459 [TBL] [Abstract][Full Text] [Related]
11. Real-world treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriasis. Wu JJ; Pelletier C; Ung B; Tian M J Med Econ; 2019 Apr; 22(4):365-371. PubMed ID: 30652520 [TBL] [Abstract][Full Text] [Related]
12. Comorbidity and economic burden among moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population. Lee S; Xie L; Wang Y; Vaidya N; Baser O J Med Econ; 2018 Jun; 21(6):564-570. PubMed ID: 29359606 [TBL] [Abstract][Full Text] [Related]
13. Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the Commercial, Medicare, and Medi-Cal Databases. Shrestha S; Miao R; Wang L; Chao J; Yuce H; Wei W Adv Ther; 2017 Aug; 34(8):1989-2006. PubMed ID: 28707285 [TBL] [Abstract][Full Text] [Related]
14. Healthcare resource utilization and costs 2 years pre- and post-lumbar spine surgery for stenosis: a national claims cohort study of 22,182 cases. Koltsov JCB; Sambare TD; Alamin TF; Wood KB; Cheng I; Hu SS Spine J; 2022 Jun; 22(6):965-974. PubMed ID: 35123048 [TBL] [Abstract][Full Text] [Related]
15. Comorbidity Burden Among Patients with Vitiligo in the United States: A Large-Scale Retrospective Claims Database Analysis. Ezzedine K; Soliman AM; Li C; Camp HS; Pandya AG Dermatol Ther (Heidelb); 2023 Oct; 13(10):2265-2277. PubMed ID: 37668899 [TBL] [Abstract][Full Text] [Related]
16. Real-World Experience With Apremilast in the Treatment of Adults With Moderate to Severe Plaque Psoriasis in Québec: A Claims-Based Analysis of Drug Utilization and Healthcare Resource Utilization. Poulin Y; Beauchemin C; Royer C; Gaudreau AJ; Yim C; Liu FF; Lachaine J J Cutan Med Surg; 2020; 24(6):573-587. PubMed ID: 32597685 [TBL] [Abstract][Full Text] [Related]
17. Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis. Armstrong A; Xia Q; John AR; Patel V; Seigel L Dermatol Ther (Heidelb); 2022 Sep; 12(9):2087-2103. PubMed ID: 35947341 [TBL] [Abstract][Full Text] [Related]
18. Direct healthcare costs and comorbidity burden among patients with psoriatic arthritis in the USA. Merola JF; Herrera V; Palmer JB Clin Rheumatol; 2018 Oct; 37(10):2751-2761. PubMed ID: 30051284 [TBL] [Abstract][Full Text] [Related]
19. Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims. Senna M; Ko J; Tosti A; Edson-Heredia E; Fenske DC; Ellinwood AK; Rueda MJ; Zhu B; King B Adv Ther; 2021 Sep; 38(9):4646-4658. PubMed ID: 34292518 [TBL] [Abstract][Full Text] [Related]
20. Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis. Wu JJ; Pelletier C; Ung B; Tian M; Khilfeh I; Curtis JR Adv Ther; 2020 May; 37(5):2098-2115. PubMed ID: 32141018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]